Clinical Trials Logo

Motion Sickness clinical trials

View clinical trials related to Motion Sickness.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06354309 Completed - Dry Eye Clinical Trials

The Impact of Immersive Virtual Reality Training on Adult: Motion Sickness, and Ocular Surface: A Pilot Study

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The research project titled "The Impact of Immersive Virtual Reality Training on Adult: Motion Sickness, and Ocular Surface: A Pilot Study" aimed to evaluate the initial safety impact of head-mounted virtual reality (HMVR) devices with virtual reality amblyopia training games on postural stability, motion sickness, and ocular surface in healthy adult participants. 38 adults (76 eyes) with normal corrected vision and stereo vision were recruited. All subjects used HMVR device for two consecutive training sessions (30 minutes each, 10 minutes intervals). Before training, after the first training and the second training, recorded the results including best corrected visual acuity (BCVA), ocular position, stereo vision, postural stability, non-invasive tear breakup time (NITBUT), tear meniscus height (TMH), red eye analysis, lipid layer classification (TFLL), eye blink frequency, eye surface temperature, simulator sickness questionnaire (SSQ) score, ocular surface disease index (OSDI) dry eye questionnaire score, visual quality questionnaire score and visual fatigue questionnaire score.

NCT ID: NCT06232785 Completed - Clinical trials for Postoperative Nausea and Vomiting

Gynecologic Endoscopic Surgery of Female Motion Sickness Patients

Start date: February 1, 2022
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to compare the analgesic effect of sufentanil and ibuprofen and the incidence of vomiting, and to choose better postoperative analgesic drugs for motion sickness patients.in describe participant population. The main questions it aims to answer are: - Whether this anesthesia method can meet the analgesic needs of gynecological laparoscopic surgery. - Whether this anesthesia method can reduce the incidence of nausea and vomiting in patients with motion sickness after gynecological laparoscopic surgery. Participants will use target-controlled infusion anesthesia combined with 0.8g ibuprofen injection. Researchers will compare with use of target-controlled infusion combined with sufentanil to see if the incidence of nausea and vomiting is higher.

NCT ID: NCT06056622 Completed - Motion Sickness Clinical Trials

Motion Sickness Rehabilitation for Virtual Reality

Start date: December 4, 2022
Phase: N/A
Study type: Interventional

The objective of this study was to investigate the effect of a rehabilitation program on motion sickness. A combined rehabilitation program will be given participants who showed motion sickness symptoms.

NCT ID: NCT05657340 Completed - Sea Sickness Clinical Trials

Video Head Impulse Test and Seasickness Susceptibility

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This a case control study on seasickness susceptibility. 86 healthy maritime personal were divided to seasickness susceptible and non susceptible groups based on a seasickness questionnaire (Golding) and motion sickness score. All subjects from both groups underwent video head impulse testing (vHIT). VHIT parameters - gain, asymmetry ect were compared between both groups.

NCT ID: NCT05640258 Completed - Seasickness Clinical Trials

Seasickness Susceptability and Vestibular Time Constant

Start date: September 18, 2017
Phase: N/A
Study type: Interventional

Participants were selected from the military navy crewmembers prior to commencing of active sailing. A vestibular time constant was calculated based on velocity step testing on a rotatory chair at baseline, 3 months and 6 month following active sailing duty. A seasickness questionnaire (WIKER) was completed during follow-up visits. study participants were divided to three groups based on WIKER score - susceptible , non-susceptible and habituating. Vestibular time constant was compared between study groups.

NCT ID: NCT05611814 Completed - Motion Sickness Clinical Trials

Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms

Start date: September 24, 2022
Phase: N/A
Study type: Interventional

Motion sickness directly impacts the readiness of the Army's aviation units. Severe motion sickness results in the dismissal of pilot and air crew candidates during initial training, while minor to moderate symptoms can be distracting during flight. The current medications on the market that target motion sickness symptoms are prohibited for use before flight. Osteopathic Manipulative Techniques are a low to no cost option, which lacks side effects, that allows Doctor of Osteopathic Medicine flight surgeons the opportunity to treat crew members without the use of pharmaceuticals. If effective, these techniques could be used to ensure aircrew readiness. Given the paucity of research on such a technique, a small, pilot study was conducted to demonstrate potential for such an approach.

NCT ID: NCT05548270 Completed - Motion Sickness Clinical Trials

Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion

Start date: August 23, 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3, randomized, double-blind, placebo-controlled study evaluating DPI-386 Nasal Gel versus placebo. Approximately 500 subjects will be randomized 1:1 (250 DPI 386 Nasal Gel/250 matching Placebo Nasal Gel) are planned to be enrolled.

NCT ID: NCT05004818 Completed - Motion Sickness Clinical Trials

Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness

Start date: August 1, 2016
Phase: N/A
Study type: Interventional

subjects with severe seasickness, who failed to habituate to sea conditions after at least six month of active sailing, were enrolled to the single-blind randomized control study. The intervention group was treated with rotatory chair stimulation at sinusoidal harmonic acceleration protocol coupled with galvanic vestibular stimulation to the mastoid processes. This unique procedure was hypothesized to promote habituation to seasickness. The control group underwent a sham procedure. All study participants filled out seasickness questionnaires at set time points following the intervention and underwent repeated step testing to determine their vestibular time constant. The number of anti-motion sickness clinic visits and scopolamine prescriptions was also recorded in the three months period following the intervention.

NCT ID: NCT04947423 Completed - Motion Sickness Clinical Trials

Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion

Start date: June 14, 2021
Phase: Phase 3
Study type: Interventional

This is a Phase 3, two-arm, randomized, double-blind, placebo-controlled, single dose efficacy and safety study evaluating the use of a nasal gel to prevent nausea and vomiting associated with motion

NCT ID: NCT04859868 Completed - Healthy Clinical Trials

Non-pharmaceutical Motion Sickness Mitigation

Start date: March 12, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is evaluate the effect of timing and magnitude on the administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the effect of Galvanic Vestibular Stimulation (GVR) amplitude on functional fitness task performance.